|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2C
|
|
pubmed:dateCreated |
2003-6-24
|
|
pubmed:abstractText |
The number of cytostatic agents effective in patients with advanced soft tissue sarcoma is limited. Trofosfamide, an alkylating agent, has been shown to be effective in several solid and haematological tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1899-901
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12820475-Administration, Oral,
pubmed-meshheading:12820475-Adult,
pubmed-meshheading:12820475-Aged,
pubmed-meshheading:12820475-Antineoplastic Agents, Alkylating,
pubmed-meshheading:12820475-Bone Neoplasms,
pubmed-meshheading:12820475-Cyclophosphamide,
pubmed-meshheading:12820475-Drug Administration Schedule,
pubmed-meshheading:12820475-Humans,
pubmed-meshheading:12820475-Liver Neoplasms,
pubmed-meshheading:12820475-Lung Neoplasms,
pubmed-meshheading:12820475-Lymphatic Metastasis,
pubmed-meshheading:12820475-Middle Aged,
pubmed-meshheading:12820475-Sarcoma
|
|
pubmed:articleTitle |
Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
|
|
pubmed:affiliation |
Tuebingen University Medical Center II, Tuebingen, Germany. joerg.hartmann@med.uni-tuebingen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
